Viewing Study NCT06132256


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2026-01-02 @ 9:21 AM
Study NCT ID: NCT06132256
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2023-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Sponsor: Syndax Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SNDX-6352-0506
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View